Major tasks (phase 1) base

Other Transaction IDV Awarded Last action

Contract number
N660012394005
Awardee
Awarding agency
Task orders
0

Award facts

Last date to order
Not on record
IDV ceiling
$47,767,019.00
Contracting staff
NAICS code
Not on record
Competition
Competed Broad Agency Announcement
Pricing
Other

Award details come from SAM.gov/FPDS.

About this IDV

Written by GovTribe AI ·

The Defense Advanced Research Projects Agency awarded an Other Transaction IDV to University of Maryland, Baltimore with a ceiling value of $47,767,019 on January 23, 2023. The Other Transaction vehicle sits outside the Federal Acquisition Regulation and operates under alternative authority to support prototype development and research efforts. University of Maryland, Baltimore is a state-controlled academic health sciences institution performing biomedical, translational, and basic research across infectious disease and immunology, vaccine development, precision medicine platforms, aging and neuroscience research, and clinical laboratory services. The institution operates as part of the University System of Maryland. This IDV is designated for major tasks in Phase 1 base performance and received an administrative modification to revise the end date. University of Maryland, Baltimore does not hold SBA set-aside certifications and competes in full-and-open procurements. The institution's federal research portfolio centers on National Institutes of Health funding streams, with recent representative work spanning NeuroBank Brain and Tissue Repository operations, radiological countermeasures dosimetry verification, vaccine fingerprinting research, and opioid use disorder clinical studies. Work is performed across Baltimore, Maryland with field and clinical sites in partner health systems.

Transactions

Action Obligated Date
Other Administrative Action P00017 · Fsharp - admin MOD to revise end date $0
Other Administrative Action P00016 · Concert - budget realignment between clins and to correct previous car amount -$32,591,950
Other Administrative Action P00015 · Concert: realign the funding by increasing option 1 by $348,636 and to decrease option 6 by $348,636 $32,591,950
Other Administrative Action P00014 · The purpose of this modification is to transfer this fsharp agreement from niwc pacific to DARPA as the issuing office. $0
Funding Only Action P00013 · P00013 - funding modification $3,601,376
Supplemental Agreement for work within scope P00012 · Descope, add tasking, obligate funds, update SOW $2,938,077
Funding Only Action P00011 · This provides INC funding. $2,627,547
Supplemental Agreement for work within scope P00010 · Exercise option 1 (phase II) and extend option task 8. $2,186,221
Funding Only Action P00009 · Major tasks (phase 1) base / incremental funding to clin 0001 $800,000
Supplemental Agreement for work within scope P00008 · Increased scope for (phase 1) base and (phase 2) option with incremental funding $7,880,686
Funding Only Action P00007 · Major tasks (phase 1) base / incremental funding to clin 0001 $556,637
Funding Only Action P00006 · The purpose of this modification is to RE-obligate incremental funds in the amount of $63,889 and revise the POP start date accordingly to clin 0002 HSR. All… $63,889
Supplemental Agreement for work within scope P00005 -$63,889
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 · Concert: consortium for optimized integration of BIO-artificial blood components for adaptive resuscitation and therapy $0
Funding Only Action P00001 · Incremental funding and admin corrections $8,562,400
Original award $3,439,006
Show all 17

Subawards

Subcontractor Amount Awarded
Kalocyte Inc. MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy. $227,748
Southwest Research Institute MAJOR TASKS (PHASE 1) BASE Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy $482,446
University Of Pittsburgh - Of The Commonwealth System Of Higher Education MAJOR TASKS (PHASE 1) BASE Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy. $196,205
University Of Pittsburgh - Of The Commonwealth System Of Higher Education MAJOR TASKS (PHASE 1) BASE Project Title: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy $651,742
SIA Partners U.s., Inc. MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy. $32,651
Haima Therapeutics LLC MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy. $31,683
Haima Therapeutics LLC MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy. -$31,683
SIA Partners U.s., Inc. MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy $44,605
University Of Pittsburgh - Of The Commonwealth System Of Higher Education MAJOR TASKS (PHASE 1) BASE The goal is to advance pre-clinical development of a whole blood analogue (WBA) $1,000,377
Vascular Solutions LLC MAJOR TASKS (PHASE 1) BASE The goal is to advance pre-clinical development of a whole blood analogue (WBA) from bio-artificial component prototypes through… $655,247
Kalocyte Inc. MAJOR TASKS (PHASE 1) BASE Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy. -$3,848
Kalocyte Inc. MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy $707,991
Southwest Research Institute EXERCISE OPTION 1 (PHASE II) AND EXTEND OPTION TASK 8. CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $922,444
Southwest Research Institute MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy $120,000
SIA Partners U.s., Inc. EXERCISE OPTION 1 (PHASE II) AND EXTEND OPTION TASK 8. CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $83,727
Southwest Research Institute MAJOR TASKS (PHASE 1) BASE CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive Resuscitation and Therapy $714,441
University Of Pittsburgh - Of The Commonwealth System Of Higher Education EXERCISE OPTION 1 (PHASE II) AND EXTEND OPTION TASK 8. CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $1,444,922
The Pennsylvania State University MAJOR TASKS (PHASE 1) BASE / INCREMENTAL FUNDING TO CLIN 0001 CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $348,630
University Of California, San Diego MAJOR TASKS (PHASE 1) BASE / INCREMENTAL FUNDING TO CLIN 0001 CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $760,115
Pumas-Ai Inc. MAJOR TASKS (PHASE 1) BASE / INCREMENTAL FUNDING TO CLIN 0001 CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $345,650
SIA Partners U.s., Inc. MAJOR TASKS (PHASE 1) BASE / INCREMENTAL FUNDING TO CLIN 0001 CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $374,459
Haima Therapeutics LLC MAJOR TASKS (PHASE 1) BASE / INCREMENTAL FUNDING TO CLIN 0001 CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $470,778
Kalocyte Inc. MAJOR TASKS (PHASE 1) BASE / INCREMENTAL FUNDING TO CLIN 0001 CONCERT: Consortium for Optimized Integration of Bio-artificial Blood Components for Adaptive… $1,199,366
Show all 23

Quick answers

Who was awarded contract N660012394005?

N660012394005 was awarded to University Of Maryland, Baltimore by Defense Advanced Research Projects Agency (Department of Defense) on January 23, 2023.

How much is contract N660012394005 worth?

N660012394005's own ceiling is $47,767,019.

Was contract N660012394005 competed?

The extent of competition for N660012394005 was competed.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV
Try for free Login